QUASISPECIES ANALYSIS OF HBV STRAINS ISOLATED FROM CHRONIC HEPATITIS B PATIENTS TREATED WITH PEG-INTERFERON plus TENOFOVIR THERAPY

被引：1
|
作者：
Lada, O. [1 ,2 ]
Zhang, Q. [1 ,2 ]
Lapalus, M. [3 ]
Laeounan, C. [4 ]
Martinot-Peignoux, M. [1 ,2 ]
Estrabaud, E. [1 ,2 ]
Boyer, N. [1 ,2 ]
Asselah, T. [1 ,2 ]
Marcellin, P. [1 ,2 ]
机构：
[1] Hop Beaujon, Serv Hepatol, Clichy, France
[2] Hop Beaujon, INSERM, CRB3, Clichy, France
[3] Hop Beaujon, INSERM, U773, Clichy, France
[4] Univ Paris 07, INSERM, UMR 738, UFR Med, Paris, France
来源：
JOURNAL OF HEPATOLOGY | 2013年 / 58卷
关键词：
D O I：
10.1016/S0168-8278(13)60756-4
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
754
引用
收藏
页码：S306 / S306
页数：1
相关论文
共 50 条
  • [31] A Potential Functional Cure in Chinese HBeAg-negative Chronic Hepatitis B Patients Treated with Peg-interferon Alpha-2a
    Chen, Xinyue
    Mao, Qianguo
    Xie, Yao
    Dou, Xiaoguang
    Xie, Qing
    Sheng, Jifang
    Gao, Zhiliang
    Zhou, Xiaoling
    Liu, Yingxia
    Zheng, Huanwei
    Zhang, Shuqin
    Li, Shibo
    Zhu, Fusheng
    Xu, Yuqin
    Zhang, Mingxiang
    Hu, Yaoren
    Chen, Xiaoping
    Huang, Yan
    Ren, Hong
    Jia, Jidong
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2019, 7 (03) : 249 - 257
  • [32] Cost-utility analysis of different peg-interferon alpha-2b plus ribavirin treatment strategies as initial therapy for naive Chinese patients with chronic hepatitis C
    Lin, W. -A.
    Tarn, Y. -H.
    Tang, S. -L.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 24 (10) : 1483 - 1493
  • [33] Low serum HBsAg and HBV DNA predict response of peg-interferon addition to entecavir in HBeAg positive chronic hepatitis B
    Liem, S.
    Hansen, B.
    Xie, Q.
    Liang, C.
    Brouwer, W. P.
    Chi, H.
    Guo, S.
    Qi, X.
    Zhang, N. -P.
    Fehmi, T.
    Campenhout, M. V.
    Janssen, H.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S518 - S519
  • [34] Flares in chronic hepatitis B patients induced by the host or the virus?: Relation to treatment response during Peg-interferon α-2b therapy
    Flink, HJ
    Sprengers, D
    Hansen, BE
    van Zonneveld, M
    de Man, RA
    Schalm, SW
    Janssen, HLA
    GUT, 2005, 54 (11) : 1604 - 1609
  • [35] Flares in chronic hepatitis B patients induced by the host or the virus?: Relation to treatment response during Peg-interferon α-2b therapy
    Flink, HJ
    Sprengers, D
    Hansen, BE
    Verhey, E
    van Zonneveld, M
    de Man, RA
    Schalm, SW
    Janssen, HLA
    JOURNAL OF HEPATOLOGY, 2005, 42 : 176 - 176
  • [36] HCC incidence in patients treated with DAA for chronic hepatitis C compared to PEG-interferon/ribavirin treated patients: HORRID study.
    Siebenhuener, Alexander Rheinhard
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [37] Immune alterations and profile of lymphocyte subsets in treatment resistant chronic hepatitis C patients, after PEG-interferon plus ribavirin combination therapy
    Macedo, G
    Lopes, S
    Ramos, JP
    Araujo, F
    Veloso, FT
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (09): : S90 - S90
  • [38] BONE MINERAL DENSITY LOSS IN TENOFOVIR TREATED CHRONIC HEPATITIS B VIRUS (HBV) PATIENTS IS A CONSEQUENCE OF VITAMIN D DEFICIENCY AND NOT TENOFOVIR THERAPY
    Gill, U. S.
    Al-Shamma, S.
    Burke, K.
    Ross, V.
    Marley, R. T. C.
    Kooner, P.
    Foster, G. R.
    Kennedy, P. T. F.
    GUT, 2011, 60 : A28 - A28
  • [39] BONE MINERAL DENSITY LOSS IN TENOFOVIR TREATED CHRONIC HEPATITIS B VIRUS (HBV) PATIENTS IS A CONSEQUENCE OF VITAMIN D DEFICIENCY AND NOT TENOFOVIR THERAPY
    Gill, Upkar
    Al-shamma, Safa
    Burke, Katherine B.
    Ross, Valerie A.
    Marley, Richard
    Kooner, Paul
    Foster, Graham R.
    Kennedy, Patrick T.
    HEPATOLOGY, 2011, 54 : 1012A - 1012A
  • [40] Peg-Interferon Alpha-2a versus Peg-Interferon Alpha-2b in Nonresponders with HCV Active Chronic Hepatitis: A Pilot Study
    Scotto, Gaetano
    Fazio, Vincenzina
    Fornabaio, Chiara
    Tartaglia, Alessandra
    Di Tullio, Rocco
    Saracino, Annalisa
    Angarano, Gioacchino
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2008, 28 (10): : 623 - 629
12345